Holly Smith Joins Profect as Director of Clinical Imaging Services
Profect Medical Technologies today announced the introduction of their Clinical Imaging Services division and the hiring of Holly Smith as its Director.
BREWSTER, NY-March 31, 2008-Profect™ Medical Technologies, a leading developer and provider of medical imaging software and clinical photography systems, today announced the introduction of their Clinical Imaging Services division and the hiring of Holly Smith as its director.
Profect™ Clinical Imaging Services will provide clients with an array of customized photographic and software services for their clinical studies including image monitoring, extrapolation of information for new drug applications and claims substantiation, and sales and marketing data for the pharmaceutical, cosmeceutical, and aesthetic medical device industries.
Holly Smith brings to the company more than twelve years of medical photographic experience, coming most recently from the Department of Plastic Surgery at the University of Texas Southwestern Medical Center where she was Chief Medical Photographer for Drs. Rod Rohrich and Jeffrey Kenkel.“Profect has quickly built a reputation for innovation and customer service in the clinical photography business,” Smith said.“I look forward to helping them extend that reputation and success into Clinical Imaging Services.”
Smith is a contributing author, photographic reviewer and photographic editor for several plastic surgery publications and speaks nationally about clinical photography.&ldquo'Holly’s expertise and, in particular, her experience advising medical professionals about the use of photography in clinical trials and in their practices make her an excellent fit for this position.She is as good as they come and we are proud and excited to be adding her to our team,” said Profect’s CEO Freddy Jones.
Smith received a Bachelor of Fine Arts in Studio Photography with an emphasis in Photography from Southern Methodist University and is a member of the National Association of Photoshop Professionals (NAPP) and the Biocommunications Association (BCA).
About Profect
Profect Medical Technologies has been offering medical imaging software and photography equipment since 2005, helping physicians to document their clinical results, standardize their photographs, and analyze the condition of their patients’ skin with quality, consistency, and reproducibility.The company offers a full line of hardware with associated digital imaging software, from the Profect Facial Studio to the Profect Full Body System and, as of March 2008, the Profect PhotoPro, an innovative, professional-grade system featuring daylight, UV and cross-polarized lighting, PictureGrip technology and Sub-Surface Skin Measurement and Analysis Tools.To learn more, visit www.profectmedical.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
